Golfdad97--Here we are in the last month of 1998. We have a new management team going into the new year.
I share the frustration from listening, for 15 years, to reasons that TCLN can't say this or that. However I won't engage in management bashing. Here's why--everyone believes that a licensing deal is imminent. I do too!! If that is the case talking publically about the interim results probably wouldn't help get the deal done. Probably hurt us. The future partner is, or will have spent alot of time and money on due diligence, reviewing confidential data, and they probably, at this time, want to keep it that way. Confidential.
TCLN has over 10 centers involved and I beleive that they have treated between 20 and 30 patients. There is alot of data. With all of this data if a deal gets done we can assume very sophisticated people have decided that this is an approvable drug. If a deal doesn't get done...we're screwed.
After a licensing deal is complete, and it seems from the consensus we won't have to wait long, our future partner may decide to publish everything, or nothing. But the simple fact that at this stage, with all the years of clinical experience someone who knows alot more than me plunked down cold, hard cash speaks volumes. That's good enough for me.
I've waited as long, or longer, than most shareholders. I'm willing to give this new mgmt team some more time. If we don't see a deal in Jan. or sooner, or some kind of report, I'll start getting nervous. |
